Azathioprine and mercaptopurine in the management of patients with chronic, active microscopic colitis

Alimentary Pharmacology and Therapeutics

Volumn 37, Issue 8, 2013, Pages 795-798

  Munch A ^a   Fernandez Banares, F ^b   Munck, L K ^c  

^a LINKÖPING UNIVERSITY   (Sweden)

^b HOSPITAL MÚTUA DE TERRASSA   (Spain)

^c Mental Health Center Glostrup   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUDESONIDE; COLESTYRAMINE; LOPERAMIDE; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; THIOPURINE METHYLTRANSFERASE;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; CLINICAL ARTICLE; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG EFFICACY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERANCE; DRUG WITHDRAWAL; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; MICROSCOPIC COLITIS; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SIDE EFFECT; THROAT DISEASE; TREATMENT RESPONSE; VOMITING;

6-MERCAPTOPURINE; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; AZATHIOPRINE; CHRONIC DISEASE; COLITIS, MICROSCOPIC; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84875219777     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12261     Document Type: Article

References (22)

1. Munch A, Aust D, Bohr J, et al,. Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis 2012; 6: 932-45.
2. Rasmussen MA, Munck LK,. Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease-microscopic colitis? Aliment Pharmacol Ther 2012; 36: 79-90.
3. Miehlke S, Heymer P, Bethke B, et al,. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology 2002; 123: 978-84.
4. Bonderup OK, Hansen JB, Birket-Smith L, et al,. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut 2003; 52: 248-51.
5. Baert F, Schmit A, D'Haens G, et al,. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 2002; 122: 20-5.
6. Chande N, McDonald JW, Macdonald JK,. Interventions for treating lymphocytic colitis. Cochrane Database Syst Rev 2008; 2: CD006096.
7. Chande N, MacDonald JK, McDonald JW,. Interventions for treating microscopic colitis: a cochrane inflammatory bowel disease and functional bowel disorders review group systematic review of randomized trials. Am J Gastroenterol 2009; 104: 235-41.
8. Gentile NMAA, Abdalla AA, Khanna S, et al,. Outcomes of patients with microscopic colitis treated with corticosteroids: a population-based study. Am J Gastroenterol 2013; 108: 256-9.
9. Miehlke S, Madisch A, Voss C, et al,. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. Aliment Pharmacol Ther 2005; 22: 1115-9.
10. Bonderup OK, Hansen JB, Teglbjaerg PS, et al,. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial. Gut 2009; 58: 68-72.
11. Pardi DS, Loftus EV Jr, Tremaine WJ, et al,. Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine. Gastroenterology 2001; 120: 1483-4.
12. Vennamaneni SR, Bonner GF,. Use of azathioprine or 6-mercaptopurine for treatment of steroid-dependent lymphocytic and collagenous colitis. Am J Gastroenterol 2001; 96: 2798-9.
13. Riddell J, Hillman L, Chiragakis L, et al,. Collagenous colitis: oral low-dose methotrexate for patients with difficult symptoms: long-term outcomes. J Gastroenterol Hepatol 2007; 22: 1589-93.
14. Münch A, Bohr J, Vigren L, Tysk C, Ström M,. Methotrexate is not effective in budesonide-refractory collagenous colitis. Gut 2011; 60 (Suppl. 3): A406.
15. Hjortswang H, Tysk C, Bohr J, et al,. Health-related quality of life is impaired in active collagenous colitis. Dig Liver Dis 2011; 43: 102-9.
16. Miehlke S, Madisch A, Bethke B, et al,. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2008; 135: 1510-6.
17. Colombel JF, Sandborn WJ, Reinisch W, et al,. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010; 362: 1383-95.
18. Hindorf U, Johansson M, Eriksson A, et al,. Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease. Aliment Pharmacol Ther 2009; 29: 654-61.
19. Hindorf U, Lindqvist M, Hildebrand H, et al,. Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease. Aliment Pharmacol Ther 2006; 24: 331-42.
20. Bjornbak C, Engel PJ, Nielsen PL, et al,. Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups. Aliment Pharmacol Ther 2011; 34: 1225-34.
21. Fernandez-Banares F, Esteve M, Espinos JC, et al,. Drug consumption and the risk of microscopic colitis. Am J Gastroenterol 2007; 102: 324-30.
22. Beaugerie L, Pardi DS,. Review article: drug-induced microscopic colitis-proposal for a scoring system and review of the literature. Aliment Pharmacol Ther 2005; 22: 277-84.